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Polar [3 + 2] cycloadditionAbstract A new synthesis of spiro[imidazo[1,2-a]pyridine-2,30-indoline]-20-ones 3a-f and
spiro[imidazo[1,2-a]isoquinoline-2,30-indolin]-20-ones 5a-d, respectively by polar [3 + 2] cycloaddi-
tion reactions of isatin-3-imines with pyridinium and isoquinolinium ylides which are derived from
2-bromoacetophenone, 2,40-dibromoacetophenone or methyl bromoacetate is described. These
cycloaddition reactions consist of the nucleophilic attack of the heteroaromatic N-ylides on
isatin-3-imine derivatives. The salient features of these processes include operational simplicity, high
yields, and easily accessible starting materials. In addition, Density Functional Theory (DFT) cal-
culations at the M06–2X/6–31 + G(d) level have been performed to investigate the possible tran-
sition states and products. The theoretical results are in good agreement with the experimental
ﬁndings and show that the product 3a is the most stable product and is formed through a kinetically
feasible pathway.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Spirocyclic systems containing one carbon atom common to
two rings are structurally interesting (Sannigrahi, 1999). The
presence of the sterically constrained spiro structure in various
natural products also adds to the interest in the investigations of
spiro compounds (Srivastav et al., 1992). These compounds rep-
resent an important class of naturally occurring substances
characteristic by their highly pronounced biological properties
such as anticancer agents (Young-Won et al., 2008; Wen-ynthesis
2 T.S. Mokhtari et al.Liang et al., 2007), antibacterial agents (Hyeong-Beom et al.,
2007), anticonvulsant agents (Krzysztof et al., 2008; Jolanta
et al., 2006), antituberculosis agents (Chande et al., 2005),
anti-Alzheimer’s agents (Masakazu et al., 2001), and antimicro-
bial agents (Thadhaney et al., 2010). Consequently, many syn-
thetic methodologies have been developed for constructing
these spirocycles, most of which were based on cycloaddition
or condensation reactions (Prakash et al., 2012; Feldman and
Karatjas, 2006). For example the synthesis of spiro neutral
products such as (±)-welwitindolinone A isonitrile I and (±)-
brevianamide A II has been reported by Wood and Williams
respectively (Reisman et al., 2008; Miller and Williams, 2009).
In the past few years a growing interest in the chemistry of
imidazo[1,2-a] pyridines and isoquinolines has been developed
due to the extent of their applications in pharmacological
science (Wisniewska et al., 2012; Hayakawa et al., 2007;
Singhaus et al., 2010). Indeed they are known for their antibac-
terial (Al-Tel et al., 2011), antiviral (Gueifﬁer et al.,
1996,1998), anti-inﬂammatory (Flores et al., 2012), antiulcer
(Katsura et al.,1992), antitubercular (Moraski et al., 2012),
anticancer (Ducray et al., 2011), antiparasitic (Martı´nez
et al., 2010) and antiprotozoa (Ismail et al., 2004) activities.
Nitrogen-containing heterocyclic compounds, are of high
industrial interest for applications as intermediates to produce
pharmaceuticals, herbicides, fungicides, dyes, etc (Pozharskii
et al., 1997). The conjugated heterocyclic N-ylides have been
known as a subgroup of mesomeric betaines (Ollis and
Stanforth, 1985), widely used as building blocks for the synthe-
sis of fused heterocyclic systems and natural products, due to
its 1,3-dipolar character (Padwa, 1984) that allows cycloaddi-
tion processes to take place efﬁciently. Today, cycloimmonium
ylides are involved in a wide range of synthetically useful reac-
tions, mainly in the ﬁeld of heterocyclic chemistry (Tewari and
Dubey, 1980). The pyridinium ylides were known as one of the
special ammonium ylides, which can react with alkenes substi-
tuted with electron-withdrawing groups to give the corre-
sponding cyclopropanes and the pyridine group has been
utilized as a leaving group in intermolecular reactions
(Kojima et al., 2000, 2006). However the 1,3-dipolar cycload-
dition of heteroaromatic N-ylides, such as isoquinolinium
ylides with electron-deﬁcient alkynes and alkenes are released
to pyrolo[2,1-a]isoquinoline derivatives (Domling and Ugi,
2000; Yan et al., 2007; Han et al., 2011). In view of our general
interest in the development of synthesis of heterocyclic com-
pounds (Seiﬁ et al., 2013; Seiﬁ and Sheibani, 2013a,b), we
now report a new synthesis of compounds 3a–f and 5d–d by
the 1,3-dipolar cyclization reactions of pyridinium and iso-
quinolinium ylides with 3-(phenylimino)indoline-2-one and 5-
bromo-3-(phenylimino)indoline-2-one in excellent yields.
Also, density function theory (DFT) calculations are carriedPlease cite this article in press as: Mokhtari, T.S. et al., Polar [3 + 2] cycloaddition of i
of spirocyclic imidazo[1,2-a]pyridine and isoquinoline derivatives. Arabian Journal oout to explore the possible transition states and minimum
energy structures of the title reaction.2. Experimental section
Melting points were measured on a Electrothermal-9100 appa-
ratus and are uncorrected. IR spectra were recorded on a
Brucker FT-IR Tensor 27 infrared spectrophotometer. 1H
NMR and spectra were recorded on a Avance III 400 or
300 MHz Bruker spectrometer. 13C NMR spectra were
recorded on the same instruments at 100 or 75 MHz using
TMS as an internal standard respectively. Mass spectra were
measured on a GCMS-QP1000 EX spectrometer at 70 eV.
Elemental analyses were performed using a Heracus
CHN-O-Rapid analyzer. The 3-(phenylimino)indoline-2-one
and 5-bromo-3-(phenylimino)indoline-2-one were known
and prepared according to a general procedure (Sridhar et al.,
2001). Pyridinium and isoquinolinium salts were prepared
according to a literature procedure (Hazra et al., 2011).
2.1. General procedure for the preparation of compounds 3a–f
and 5a–d in acetonitrile
A solution of pyridinium salts (1a–c) or isoquinolinium salts
(4a, c) (2 mmol), 3-(phenylimino)indoline-2-one (2a) or 5-bro
mo-3-(phenylimino)indoline-2-one (2b) (2 mmol) and triethy-
lamine (0.2 mL) in acetonitrile (20 mL) was stirred at room
temperature for about 60 min (the progress of the reaction
being monitored by TLC and using n-hexane/ethyl acetate as
an eluent). The solvent was diluted with 50 mL of water and
the resulting precipitate was collected with ﬁltration. The crude
product was recrystallized with dichloromethane/n-hexane to
give the pure solid sample for analysis.
2.2. Spectral data for selected compounds
2.2.1. 3-Benzoyl-1-phenyl-3,8a-dihydro-1H-spiro[imidazo[1,2-
a]pyridine-2,30-indolin]-20-one (3a)
Green crystals; yield: 95%; mp 178–181 C; IR (KBr) mmax
(cm1): 3170 (NH-amid), 1741, 1651(C‚O), 1608, 1590
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 10.99 (s, 1H,
NACH‚), 8.35 (s, 1H, NH), 7.60–6.32 (m, 18H, Ar,
CH‚CH), 5.80 (s, 1H, NACHAN). 13C NMR (100 MHz,
DMSO-d6, ppm): 163.51 (C‚O), 158.46 (NAC‚O), 155.01,
152.84, 150.57, 149.03, 147.01, 145.70, 134.46, 134.20, 129.63,
128.33, 125.38, 124.96, 124.47, 122.78, 122.32, 121.72, 119.07,
117.25, 115.68, 111.57 (NACAN), 110.80 (spiro carbon). MS
(m/z): 419 (M+) (3), 368 (4), 264 (4), 222 (90), 194 (100), 167
(24), 139 (4), 105 (16), 77 (51), 51 (23). Anal. calcd. for
C27H21N3O2: C, 77.31; H, 5.05; N, 10.00%. Found: C, 77.02;
H, 4.87; N, 9.69%.
2.2.2. 3-Benzoyl-50-bromo-1-phenyl-3,8a-dihydro-1H-
spiro[imidazo[1,2-a]pyridine-2,30-indolin]-20-one (3b)
Green crystals; yield: 92%; mp 190 C (decompose); IR (KBr)
mmax (cm1): 3251 (NH), 1740, 1651 (C‚O), 1608 (C‚C). 1H
NMR (400 MHz, DMSO-d6, ppm): 11.16 (s, 1H, NACH‚),
8.57 (s, 1H, NH), 7.51–6.34 (m, 17H, Ar, CH‚CH), 5.50 (s,
1H, NACHAN). 13C NMR (100 MHz, DMSO-d6, ppm):
167.85 (C‚O), 154.07 (NAC‚O), 150.19, 149.58, 147.44,satin-3-imines with electrophilically activated heteroaromatic N-ylides: Synthesis
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125.02, 124.88, 119.25, 117.32, 117.13, 113.55, 113.51, 112.87,
112.76 (NACAN), 108.67 (spiro carbon). MS (m/z): 497
(M+) (2), 396 (3), 368 (3), 302 (61), 274 (100), 245 (6), 192
(19), 166 (25), 116 (11), 105 (9), 90 (11), 77 (75), 51 (41).
Anal. calcd. for C27H20BrN3O2: C, 65.07; H, 4.04; N, 8.43%.
Found: C, 64.72; H, 3.86; N, 8.09%.
2.2.3. 3-(4-Bromobenzoyl)-1-phenyl-3,8a-dihydro-1H-
spiro[imidazo[1,2-a]pyridine-2,30-indolin]-20-one (3c)
Green crystals; yield: 92%; mp 165 C (decompose); IR (KBr)
mmax (cm1): 3173 (NH), 1747, 1651 (C‚O), 1612, 1589
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.01 (s, 1H,
NACH‚), 8.74 (s, 1H, NH), 7.50–6.33 (m, 17H, Ar,
CH‚CH), 5.42 (s, 1H, NACHAN). 13C NMR (100 MHz,
DMSO-d6, ppm): 163.45, 154.95, 150.53, 146.94, 134.44,
134.18, 131.20, 129.59, 128.28, 127.89, 127.62, 126.09. 125.34,
124.91, 124.42, 122.75, 122.29, 121.70, 119.02, 117.19, 115.65,
111.50 (NACAN), 110.72 (spiro carbon). MS (m/z): 497
(M+) (2), 393 (5), 368 (17), 313 (20), 264 (17), 222 (33), 194
(70), 161 (25), 118 (26), 97 (44), 79 (100), 57 (87).
2.2.4. 50-Bromo-3-(4-bromobenzoyl)-1-phenyl-3,8a-dihydro-
1H-spiro[imidazo[1,2-a]pyridine-2,30-indolin]-20-one (3d)
Green crystals; yield: 90%; mp 187 C (decompose); IR (KBr)
mmax (cm1): 3253 (NH), 1740, 1652 (C‚O), 1608, 1588
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.16 (s, 1H,
NACH‚), 8.59 (s, 1H, NH), 7.52–6.34 (m, 16H, Ar,
CH‚CH), 5.48 (s, 1H, NACHAN). 13C NMR (100 MHz,
DMSO-d6, ppm): 165.26, 154.08, 150.19, 146.03, 139.69,
136.48, 136.25, 133.74, 131.42, 129.66, 128.29, 127.56, 125.28,
125.02, 124.88, 123.37, 121.59, 119.26, 117.32, 117.13, 113.55,
112.87 (NACAN), 110.02 (spiro carbon). MS (m/z): 577
(M+) (2), 475 (3), 422 (5), 368 (2), 302 (57), 274 (100), 245
(6), 192 (19), 166 (23), 116 (12), 90 (10), 77 (64), 51(32).
Anal. calcd. for C27H19Br2N3O2: C, 56.18; H, 3.32; N,
7.28%. Found: C, 55.85; H, 3.09; N, 6.94%.
2.2.5. Methyl 20-oxo-1-phenyl-3,8a-dihydro-1H-
spiro[imidazo[1,2-a]pyridine-2,30-indoline]-3-carboxylate (3e)
Orange crystals; yield: 92%; mp 215–218 C; IR (KBr) mmax
(cm1): 3174 (NH), 1748 (C‚O), 1648 (C‚O), 1612, 1594
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.00 (s, 1H,
NCH‚), 8.66 (s, 1H, NH), 7.60–6.32 (m, 13H, Ar,
CH‚CH), 5.76 (s, 1H, NACHAN), 3.67 (s, 3H, CH3).
13C
NMR (100 MHz, DMSO-d6, ppm): 163.66, 158.42, 154.71,
150.53, 149.34, 146.80, 145.63, 134.43, 129.78, 128.28, 125.33,
124.80, 122.83, 121.88, 119.11, 117.19, 115.70, 111.48
(NACAN), 110.74 (spiro carbon), 54.92 (OCH3). MS (m/z):
373 (M+) (3), 369 (2), 274 (5), 222 (87), 194 (100), 167 (22),
118 (9), 90 (11), 77 (42), 51 (20). Anal. calcd. for
C22H19N3O3: C, 70.76; H, 5.13; N, 11.25%. Found: C, 70.42;
H, 3.96; N, 10.89%.
2.2.6. Methyl 50-bromo-20-oxo-1-phenyl-3,8a-dihydro-1H-
spiro[imidazo[1,2-a]pyridine-2,30-indoline]-3-carboxylate (3f)
Orange crystals; yield: 90%; mp 240 C (decompose); IR (KBr)
mmax (cm1): 3257 (NH), 1740, 1649 (C‚O), 1608, 1590
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.15 (s, 1H,
NCH‚), 8.78 (s, 1H, NH), 7.52–6.33 (m, 12H, Ar,Please cite this article in press as: Mokhtari, T.S. et al., Polar [3 + 2] cycloaddition of i
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13C
NMR (100 MHz, DMSO-d6, ppm): 162.97, 154.07, 150.18,
145.96, 138.81, 136.47, 136.24, 129.65, 128.29, 127.56, 125.28,
125.02, 123.36, 119.26, 117.28, 117.13, 113.52, 112.87
(NACAN), 104.86 (spiro carbon), 53.27 (OCH3). MS (m/z):
451 (M+) (2), 368 (4), 302 (59), 274 (100), 245 (6), 192 (20),
166 (27), 116 (12), 90 (12), 77 (74), 51 (37).
2.2.7. 3-Benzoyl-1-phenyl-3,10b-dihydro-1H-spiro[imidazo[2,1-
a]isoquinoline-2,30-indolin]-20-one (5a)
Orange crystals; yield: 93%; mp 154 C (decompose); IR (KBr)
mmax (cm1): 3259 (NH), 1739, 1664 (C‚O), 1618, 1597
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 10.82 (s, 1H,
NCH‚), 8.96 (s, 1H, NH), 7.78–6.51 (m, 20H, Ar,
CH‚CH), 5.39 (s, 1H, NACHAN). 13C NMR (100 MHz,
DMSO-d6, ppm): 163.45 (C‚O), 154.94, 150.53, 146.94,
138.37, 135.42, 134.43, 134.17, 133.70, 132.11, 129.58, 128.73,
128.28, 127.94, 127.14, 125.79, 125.33, 125.09, 124.91, 123.31,
122.75, 122.29, 121.69, 119.02, 117.19, 111.50 (NACAN),
100.42 (spiro carbon). MS (m/z): 469 (M+) (3), 414 (3), 358
(9), 298 (3), 264 (10), 159 (10), 129 (4), 105 (100), 77 (65), 51
(14). Anal. calcd. for C31H23N3O2: C, 79.30; H, 4.94; N,
8.95%. Found: C, 79.02; H, 4.78; N, 8.59%.
2.2.8. 3-Benzoyl-50-bromo-1-phenyl-3,10b-dihydro-1H-
spiro[imidazo[2,1-a]isoquinoline-2,30-indolin]-20-one (5b)
Orange crystals; yield: 92%; mp 160 C (decompose); IR (KBr)
mmax (cm1): 3253 (NH), 1740, 1664 (C‚O), 1611, 1579
(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.17 (s, 1H,
NCH‚), 8.52 (s, 1H, NH), 7.97–6.87 (m, 19H, Ar,
CH‚CH), 5.57 (s, 1H, NACHAN). 13C NMR (100 MHz,
DMSO-d6, ppm): 168.09), 154.07, 150.19, 146.03, 138.47,
138.37, 136.47, 136.25, 135.44, 133.69, 132.11, 129.65, 128.81,
128.73, 128.29, 127.94, 127.56, 127.19, 125.79, 125.27, 125.09,
123.30, 119.26, 117.13, 113.53, 112.87 (NACAN), 100.41
(spiro carbon). MS (m/z): 547 (M+) (2), 475 (7), 425 (2), 385
(3), 358 (8), 300 (4), 254 (8), 213 (6), 164 (4), 129 (9), 105
(100), 77 (63), 51 (10). Anal. calcd. for C31H22BrN3O2: C,




Orange crystals; yield: 93%; mp 175 C (decompose); IR (KBr)
mmax (cm1): 3243 (broad, OH enol form and NH), 1748, 1652
(C‚O), 1615, 1591 (C‚C). 1H NMR (400 MHz, DMSO-d6,
ppm): 11.00 (s, 1H, NCH‚), 8.75 (s, 1H, NH), 7.50–6.33
(m, 15H, Ar, CH‚CH), 5.40 (s, 1H, NACHAN), 3.67 (s,
3H, CH3).
13C NMR (100 MHz, DMSO-d6, ppm): 163.45,
154.94, 150.53, 146.94, 137.29, 134.53, 134.17, 129.58, 128.75,
128.28, 125.33, 124.91, 124.42, 122.74, 122.28, 121.69, 119.67,
119.02, 117.19, 115.65, 111.50, 111.45 (NACAN), 110.72
(spiro carbon), 53.92 (OCH3). MS (m/z): 423 (M
+) (4), 412
(12), 368 (11), 313 (12), 255 (10), 236 (22), 222 (60), 194
(100), 167 (23), 129 (99), 93 (35), 77 (76), 51 (35).
2.2.10. Methyl 50-bromo-20-oxo-1-phenyl-3,10b-dihydro-1H-spiro-
[imidazo[2,1-a]isoquinoline-2,30-indoline]-3-carboxylate (5d)
Orange crystals; yield: 90%; mp 250 C (decompose); IR (KBr)
mmax (cm1): 3258 (NH), 1740, 1650 (C‚O), 1609, 1590satin-3-imines with electrophilically activated heteroaromatic N-ylides: Synthesis
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4 T.S. Mokhtari et al.(C‚C). 1H NMR (400 MHz, DMSO-d6, ppm): 11.15 (s, 1H,
NCH‚), 8.84 (s, 1H, NH), 7.52–6.34 (m, 14H, Ar,
CH‚CH), 5.55 (s, 1H, NACHAN), 3.68 (s, 3H, CH3).
13C
NMR (100 MHz, DMSO-d6, ppm): 165.09, 154.07, 150.19,
146.03, 140.78, 136.25, 134.41, 131.38, 129.66, 128.29, 127.56,
125.28, 125.03, 124.88, 119.88, 119.26, 117.30, 117.13, 113.54,
112.87, 112.77 (NACAN), 110.33 (spiro carbon), 53.71Table 1 Solvent and base effects on the reaction of pyri-
dinium or isoquinolinium bromides with 3-(phenylimino)indo-
line-2-one 2a.
Compound, No. Solvent Base Time (min) Yield (%)
3a Acetonitrile Et3N 60 95
3a Acetonitrile K2CO3 67 90
3a Toluene Et3N 80 82
3a Toluene K2CO3 90 80
3a CH2Cl2 Et3N 65 90
3a CH2Cl2 K2CO3 75 88
5a Acetonitrile Et3N 60 93
5a Acetonitrile K2CO3 65 90
5a Toluene Et3N 77 85
5a Toluene K2CO3 85 82
5a CH2Cl2 Et3N 70 90
5a CH2Cl2 K2CO3 75 87
Scheme 1 1,3-Dipolar cyclization reaction of py
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+) (2), 431 (5), 368 (7), 302 (57),
274 (100), 245 (6), 192 (20), 166 (27), 129 (9), 116 (13), 90
(12), 77 (75), 51 (36). Anal. calcd. for C26H20BrN3O3: C,
62.16; H, 4.01; N, 8.36%. Found: C, 61.85; H, 3.78; N, 8.01%.
3. Results and discussions
In the present work, we report a new synthesis of compounds
3a–f and 5a–d, which are prepared by the reaction of isatin-3-
imines 2a, b with pyridinium and isoquinolinium ylides under
mild conditions at ambient temperature in excellent yields. In
order to optimize the reaction conditions, we used some polar
and non polar solvents in the reaction of pyridinium or iso-
quinolinium bromides with 3-(phenylimino)indoline-2-one 2a
in the presence of triethylamine or potassium carbonate as a
base. The results are shown in Table 1. It is noteworthy to
mention that the polar solvents such as acetonitrile and
dichloromethane, which afford better yields than toluene as
a nonpolar solvent, and acetonitrile and triethylamine are
the most effective solvent and base respectively.
Isatin-3-imines 2a, b which are prepared by reacting isatins
and aniline, are interesting electrophilic reagents for synthesis
of spiro compounds. Pyridinium ylides I which were prepared
in situ from the pyridinium salts 1a–c, were stirred with isatin-
3-imines 2a and b in CH3CN at room temperature to give spiroridinium ylides I with isatin-3-imines (2a, b).
satin-3-imines with electrophilically activated heteroaromatic N-ylides: Synthesis
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Polar [3 + 2] cycloaddition of isatin-3-imines with electrophilically activated heteroaromatic N-ylides 5compounds 3a–f by the 1,3-dipolar cyclization reaction in
excellent yields (Scheme 1).
The pyridinium ylides were known as one of special ammo-
nium ylides, which can react with alkenes substituted with
electron-withdrawing groups to give the corresponding cyclo-
propanes and the pyridine group has been utilized as a leaving
group in intermolecular reactions (Kojima et al., 2006).
However the 1,3-dipolar cycloaddition reactions of pyridinium
ylides with various perﬂuoroalkenes, perﬂuoroazaoleﬁns and
triﬂuoroacetonitrile to synthesize monoﬂuoro or triﬂuo-
romethyl substituted heterocycles, such as pyrazolo[1,2-
a]pyridines and indolizines have been reported (Fang et al.,
2004). According to Scheme 1, we ﬁnd that the reaction of
pyridinium ylides I with isatin-3-imines 2a, b that bear imine
group as electron-withdrawing released only spiro compounds
(3a–f). Under the same conditions when the isoquinolinium
ylides which were prepared in situ from the reaction
of isoquinolinium bromides (4a, c) were treated with
isatin-3-imines (2a, b), spiro derivatives 5a–d via 1,3-dipolar
cycloaddition reactions were obtained in excellent yields
(Scheme 2).Scheme 2 Reaction of isoquinolinium brom
Figure 1 Relative energies of the stationary points arising from t
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tions at the M06-2X/6-31G* (Zhao and Truhlar, 2008) level of
theory are performed to optimize the geometries for the possi-
ble transition states (TS1 and TS2) and products 4 and 3a
which were released from the reaction of 2-oxo-2-phenyl-1-(p
yridin-1-ium-1-yl)ethan-1-ide (Ia) with 3-(phenylimino)
indolin-2-one (2a). The relative energies of these species are
depicted in Fig. 1.
As it is seen, the most stable product is 3a with the relative
energy of 102.5 kJ mol1. The calculations reveal that 3a is
formed via a concerted mechanism (TS1 in Fig. 1) with the
very low barrier height of 5.2 kJ mol1. Therefore, it is a kinet-
ically feasible reaction pathway. It is found that a barrier
height of 187.8 kJ mol1 (TS2 in Fig. 1) should be surmounted
for the formation of 4. The relative energy of the product 3a is
69.9 kJ mol1. As a result, the latter product is not important
from both kinetics and thermodynamics stand points.
The structure of compounds 3a–f and 5a–d was determined
on the basis of their elemental analyses, mass spectrum, 1H and
13C NMR and IR spectroscopic data. Only one product was
obtained in each case.ides (4a, c) with isatin-3-imines (2a, b).
he reaction of I with 2a computed at the M06-2X/6-31+G(d).
satin-3-imines with electrophilically activated heteroaromatic N-ylides: Synthesis
f Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.05.023
6 T.S. Mokhtari et al.4. Conclusions
In summary, we have investigated the [3 + 2] cycloaddition
reaction between heteroaromatic N-ylides, such as pyridinium
or isoquinolinium ylides with 3-(phenylimino)indoline-2-one
and 5-bromo-3-(phenylimino)indoline-2-one which lead to
the formation of corresponding spiro[imidazo[1,2-a]pyridine-
2,30-indoline]-20-one and spiro[imidazo[1,2-a]isoquinoline-2,30-
indolin]-20-one derivatives respectively. Prominent among the
advantages of these reactions are high conversions, short reac-
tion times and cleaner reaction proﬁles. Further expansion of
the synthesis of spiro compounds with potential biological
activity is in progress in our laboratory.
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